TNF and neoplasm: However, based on the dual role of the ncRNA/PDCD4 pathway in tumor and inflammatory diseases, research on anticancer interventions must ensure that targeting ncRNA/PDCD4 would not render the side effects that induce an inflammatory response, such as endothelial inflammatory damage through the NF-κB/TNF-α signaling pathway (1).